Pain with Differing Intraperitoneal Washes At the End of Laparoscopic Gynecologic Surgery

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Tennessee

About this trial

We hypothesize that instilling intraperitoneal Marcaine (without epinephrine) at the end of a non-total laparoscopic gynecologic surgery (adnexa only, which includes the ovaries, fallopian tubes, and associated ligaments, vessels, and connective tissue) will result in less pain and reduced opioid use postoperatively.

Eligibility criteria

Qualifiers

Age 18 years and older

Undergoing planned laparoscopic adnexal surgery as a day surgery procedure; The surgical site is the "adnexa" which contains the ovaries, fallopian tubes, and associated ligaments, vessels, and connective tissue. The "adnexa" does not include the uterus.

BMI 55.0 or less

Disqualifiers

Under age 18

Undergoing a non-laparoscopic unplanned surgical procedure Patients having a laparoscopic partial or complete removal of the uterus, a hysterectomy, will NOT be included in this study population for enrollment.

septicemia

severe hemorrhage

Trial design

Treatments tested in this trial

  • Normal Saline (0.9% NaCl)
  • Marcaine hydrochloride without epinephrine 0.5%

Treatment groups

96 Participants
are divided into 2 treatment groups

Sponsors and collaborators